IN2014CN03130A - - Google Patents
Info
- Publication number
- IN2014CN03130A IN2014CN03130A IN3130CHN2014A IN2014CN03130A IN 2014CN03130 A IN2014CN03130 A IN 2014CN03130A IN 3130CHN2014 A IN3130CHN2014 A IN 3130CHN2014A IN 2014CN03130 A IN2014CN03130 A IN 2014CN03130A
- Authority
- IN
- India
- Prior art keywords
- represent
- npt
- preventive
- formula
- iib
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 201000005991 hyperphosphatemia Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000003449 preventive effect Effects 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 1
- 108010092528 Phosphate Transport Proteins Proteins 0.000 abstract 1
- 102000016462 Phosphate Transport Proteins Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
- -1 thiophene compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
- C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011236533 | 2011-10-27 | ||
| PCT/JP2012/077660 WO2013062065A1 (ja) | 2011-10-27 | 2012-10-25 | アミノアルキル置換n-チエニルベンズアミド誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN03130A true IN2014CN03130A (ja) | 2015-07-03 |
Family
ID=48167891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3130CHN2014 IN2014CN03130A (ja) | 2011-10-27 | 2012-10-25 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9062032B2 (ja) |
| EP (1) | EP2772490B1 (ja) |
| JP (2) | JP2013107880A (ja) |
| KR (1) | KR101941048B1 (ja) |
| CN (1) | CN103906741B (ja) |
| AR (1) | AR088563A1 (ja) |
| AU (1) | AU2012329913A1 (ja) |
| BR (1) | BR112014010169B1 (ja) |
| CA (1) | CA2853688C (ja) |
| EA (1) | EA023955B1 (ja) |
| ES (1) | ES2585415T3 (ja) |
| IL (1) | IL232230A0 (ja) |
| IN (1) | IN2014CN03130A (ja) |
| MX (1) | MX342521B (ja) |
| PH (1) | PH12014500887A1 (ja) |
| PL (1) | PL2772490T3 (ja) |
| TW (1) | TW201323419A (ja) |
| WO (1) | WO2013062065A1 (ja) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102160320B1 (ko) | 2012-10-02 | 2020-09-28 | 에피테라퓨틱스 에이피에스 | 히스톤 탈메틸효소의 저해제 |
| US9499553B2 (en) | 2013-03-13 | 2016-11-22 | Chugai Seiyaku Kabushiki Kaisha | Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same |
| SI2975030T1 (sl) | 2013-03-13 | 2020-10-30 | Chugai Seiyaku Kabushiki Kaisha | Derivat dihidropiridazin-3,5-diona |
| TWI594975B (zh) | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
| WO2015018823A1 (en) | 2013-08-08 | 2015-02-12 | Galapagos Nv | Thieno[2,3-c]pyrans as cftr modulators |
| WO2015064532A1 (ja) * | 2013-10-30 | 2015-05-07 | 第一三共株式会社 | モルホリン化合物 |
| WO2015153498A1 (en) * | 2014-03-31 | 2015-10-08 | Epitherapeutics, Aps | Inhibitors of histone demethylases |
| CN105658635B (zh) * | 2014-08-22 | 2019-03-08 | 江苏恒瑞医药股份有限公司 | 噻吩并环烷基或噻吩并杂环基类衍生物、其制备方法及其在医药上的应用 |
| WO2016039458A1 (ja) | 2014-09-12 | 2016-03-17 | 中外製薬株式会社 | ナトリウム依存性リン酸トランスポーター阻害剤を含有する医薬 |
| CN107074793B (zh) | 2014-09-26 | 2019-08-23 | 第一三共株式会社 | 二羧酸化合物的盐 |
| CN105524053B (zh) * | 2014-10-19 | 2020-06-05 | 广东东阳光药业有限公司 | 四氢苯并噻吩化合物 |
| TW201700458A (zh) | 2015-04-24 | 2017-01-01 | 第一三共股份有限公司 | 二羧酸化合物之製法 |
| CN107082773B (zh) * | 2016-02-16 | 2020-07-28 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的硫酸盐及其结晶形式 |
| CA3033628C (en) * | 2016-08-15 | 2021-01-12 | Eli Lilly And Company | Condensed thiophene derivatives useful as napi-iib inhibitors |
| JOP20190080A1 (ar) | 2016-10-14 | 2019-04-11 | Bayer Pharma AG | مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها |
| CN109422723B (zh) * | 2017-08-25 | 2021-02-23 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的晶型及其制备方法 |
| AR126060A1 (es) | 2021-06-08 | 2023-09-06 | Chugai Pharmaceutical Co Ltd | Método para producir derivado de dihidropiridazin-3,5-diona |
| BR112023023708A2 (pt) | 2021-06-08 | 2024-01-30 | Chugai Pharmaceutical Co Ltd | Formulação contendo derivado de di-hidropiridazino-3,5-diona |
| WO2023203254A2 (en) | 2022-04-22 | 2023-10-26 | Fundamental Pharma Gmbh | Effective means to modulate nmda receptor-mediated toxicity |
| US20250302833A1 (en) | 2022-05-11 | 2025-10-02 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition for treating or preventing cystic disease |
| WO2024223617A1 (en) | 2023-04-24 | 2024-10-31 | Fundamental Pharma Gmbh | Effective means to modulate nmda receptor-mediated toxicity |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002213048A1 (en) * | 2000-10-05 | 2002-04-15 | Smith Kline Beecham Corporation | Phosphate transport inhibitors |
| JP2007131532A (ja) * | 2001-09-28 | 2007-05-31 | Kirin Brewery Co Ltd | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 |
| AU2002354410A1 (en) | 2001-12-05 | 2003-06-17 | Japan Tobacco Inc. | Triazole compound and medicinal use thereof |
| EP1614676A4 (en) | 2003-03-27 | 2009-03-25 | Kirin Pharma Kk | CONNECTION TO INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICAMENT CONTAINING THEREOF |
| WO2006093518A2 (en) | 2004-06-25 | 2006-09-08 | Apath, Llc | Thienyl compounds for treating virus-related conditions |
| CA2579089A1 (en) | 2004-08-30 | 2006-03-09 | Government Of The United States Of America As Represented By The Secreta Ry Department Of Health And Human Services | Inhibition of viruses using rnase h inhibitors |
| JP2008517061A (ja) | 2004-10-20 | 2008-05-22 | コンパス ファーマシューティカルズ リミティド ライアビリティ カンパニー | 抗腫瘍剤としての化合物及びそれらの使用 |
| US8084612B2 (en) * | 2008-01-08 | 2011-12-27 | Purdue Pharma L.P. | Proline analogs as ligands for cannabinoid receptors |
| MX2012012421A (es) | 2010-04-28 | 2012-12-17 | Astellas Pharma Inc | Compuestos tetrahidrobenzotiofena. |
| EP2590510B1 (en) | 2010-07-07 | 2016-09-28 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| WO2012006474A2 (en) * | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| WO2012054110A2 (en) | 2010-07-07 | 2012-04-26 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| ES2547890T3 (es) | 2010-07-07 | 2015-10-09 | Ardelyx, Inc. | Compuestos y métodos para inhibir el transporte de fosfato |
| EP2591354B1 (en) | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
-
2012
- 2012-10-25 JP JP2012236135A patent/JP2013107880A/ja active Pending
- 2012-10-25 ES ES12844048.4T patent/ES2585415T3/es active Active
- 2012-10-25 CA CA2853688A patent/CA2853688C/en not_active Expired - Fee Related
- 2012-10-25 PH PH1/2014/500887A patent/PH12014500887A1/en unknown
- 2012-10-25 KR KR1020147014256A patent/KR101941048B1/ko not_active Expired - Fee Related
- 2012-10-25 MX MX2014005090A patent/MX342521B/es active IP Right Grant
- 2012-10-25 TW TW101139423A patent/TW201323419A/zh unknown
- 2012-10-25 CN CN201280053147.6A patent/CN103906741B/zh not_active Expired - Fee Related
- 2012-10-25 JP JP2013540835A patent/JP6020460B2/ja not_active Expired - Fee Related
- 2012-10-25 EA EA201490875A patent/EA023955B1/ru not_active IP Right Cessation
- 2012-10-25 PL PL12844048.4T patent/PL2772490T3/pl unknown
- 2012-10-25 BR BR112014010169-8A patent/BR112014010169B1/pt not_active IP Right Cessation
- 2012-10-25 AU AU2012329913A patent/AU2012329913A1/en not_active Abandoned
- 2012-10-25 IN IN3130CHN2014 patent/IN2014CN03130A/en unknown
- 2012-10-25 WO PCT/JP2012/077660 patent/WO2013062065A1/ja not_active Ceased
- 2012-10-25 US US14/354,086 patent/US9062032B2/en active Active
- 2012-10-25 EP EP12844048.4A patent/EP2772490B1/en active Active
- 2012-10-26 AR ARP120104035A patent/AR088563A1/es unknown
-
2014
- 2014-04-24 IL IL232230A patent/IL232230A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX342521B (es) | 2016-10-03 |
| EA201490875A1 (ru) | 2014-09-30 |
| CA2853688A1 (en) | 2013-05-02 |
| AU2012329913A1 (en) | 2014-05-22 |
| MX2014005090A (es) | 2015-02-12 |
| JP6020460B2 (ja) | 2016-11-02 |
| PH12014500887A1 (en) | 2019-06-03 |
| BR112014010169A2 (pt) | 2017-04-25 |
| KR20140096322A (ko) | 2014-08-05 |
| JP2013107880A (ja) | 2013-06-06 |
| US20150031727A1 (en) | 2015-01-29 |
| EP2772490A4 (en) | 2015-01-21 |
| EA023955B1 (ru) | 2016-07-29 |
| AR088563A1 (es) | 2014-06-18 |
| TW201323419A (zh) | 2013-06-16 |
| JPWO2013062065A1 (ja) | 2015-04-02 |
| WO2013062065A1 (ja) | 2013-05-02 |
| IL232230A0 (en) | 2014-06-30 |
| CN103906741A (zh) | 2014-07-02 |
| EP2772490B1 (en) | 2016-04-06 |
| KR101941048B1 (ko) | 2019-01-22 |
| ES2585415T3 (es) | 2016-10-05 |
| EP2772490A1 (en) | 2014-09-03 |
| US9062032B2 (en) | 2015-06-23 |
| BR112014010169B1 (pt) | 2021-12-07 |
| PL2772490T3 (pl) | 2016-11-30 |
| CA2853688C (en) | 2018-06-12 |
| CN103906741B (zh) | 2016-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN03130A (ja) | ||
| IN2015MN00405A (ja) | ||
| TN2011000400A1 (en) | Inhibitors of beta-secretase | |
| MX348422B (es) | Inhibidores de arginasa y sus aplicaciones terapeuticas. | |
| BR112014017749A8 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
| MX336381B (es) | Boronatos como inhibidores de arginasa. | |
| MX356342B (es) | Agente de control de endoparásitos y método para usarlo. | |
| IN2014CN00712A (ja) | ||
| TN2014000122A1 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| EA026931B9 (ru) | Гербицидно и фунгицидно действующие 5-оксизамещенные 3-фенилизоксазолин-5-карбоксамиды и 5-оксизамещенные 3-фенилизоксазолин-5-тиоамиды или их соли | |
| GEP20146197B (en) | New compounds | |
| MX351812B (es) | Derivados de piridona. | |
| TN2015000245A1 (en) | Heterocyclic compound | |
| UA108926C2 (ru) | LibreOffice? [2,3-D] +" +" !+ | |
| MA35402B1 (fr) | Compositions pesticides et procédés associés | |
| AU2012258977A8 (en) | Inhibitors of LRRK2 kinase activity | |
| MY172924A (en) | Neprilysin inhibitors | |
| MY167898A (en) | Co-crystals and salts of ccr3-inhibitors | |
| IN2014CN04204A (ja) | ||
| PH12012500542A1 (en) | Substituted amide compound | |
| IN2013CN01335A (ja) | ||
| IN2012DN02502A (ja) | ||
| IN2014CN04449A (ja) | ||
| MY170262A (en) | Dicarboxylic acid compound |